Gilles Martin - Eurofins Scientific Chairman and CEO

ERFSF Stock  USD 48.45  0.91  1.91%   

Chairman

Dr. Gilles G. Martin is Chairman of the Board and Chief Executive Officer of Eurofins Scientific SE. He graduated from Ecole Centrale de Paris, and subsequently obtained a MS degree from Syracuse University and a Ph.D. in statistics and applied mathematics. In 1988, he founded the original food authenticity laboratory of Eurofins Scientific Nantes food authentiicty laboratory. He is a member of the Board of Directors of Brucker Corporationration, serving as an independent director. Dr. Martin is also a past President of the French Association of private analytical laboratories APROLAB, and of the North American Technical Committee for Juice and Juice Products and of public bodies supporting innovation and entrepreneurship.
Age 60
Phone352 26 18 53 20
Webhttps://www.eurofins.com

Eurofins Scientific Management Efficiency

The company has return on total asset (ROA) of 0.075 % which means that it generated a profit of $0.075 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1521 %, meaning that it generated $0.1521 on every $100 dollars invested by stockholders. Eurofins Scientific's management efficiency ratios could be used to measure how well Eurofins Scientific manages its routine affairs as well as how well it operates its assets and liabilities.
Eurofins Scientific SE has accumulated 2.08 B in total debt with debt to equity ratio (D/E) of 0.7, which is about average as compared to similar companies. Eurofins Scientific has a current ratio of 1.3, suggesting that it is not liquid enough and may have problems paying out its financial obligations in time and when they become due. Debt can assist Eurofins Scientific until it has trouble settling it off, either with new capital or with free cash flow. So, Eurofins Scientific's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Eurofins Scientific sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Eurofins to invest in growth at high rates of return. When we think about Eurofins Scientific's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 7 records

CHAIRMAN Age

Jim ManziThermo Fisher Scientific
68
Christopher OConnellWaters
51
Thomas LynchThermo Fisher Scientific
66
Mitchell RalesDanaher
67
Flemming OrnskovWaters
62
Steven RalesDanaher
73
Boon KohAgilent Technologies
70
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg. Eurofins Scientific operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 61000 people. Eurofins Scientific SE [ERFSF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Eurofins Scientific Leadership Team

Elected by the shareholders, the Eurofins Scientific's board of directors comprises two types of representatives: Eurofins Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Eurofins. The board's role is to monitor Eurofins Scientific's management team and ensure that shareholders' interests are well served. Eurofins Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Eurofins Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
Gilles Martin, Chairman and CEO
Yvoine Remy, VP Europe
Rajesh Saigal, Ex Asia
David Bryant, Sr America
Laurent Lebras, Group Director
Sandra Hoeylaerts, Chief Officer
Joachim Reichelt, VP Europe
Gabriel Julia, VP Europe
Valerie Hanote, Non-Executive Director
Timothy Oostdyk, Genomics BioPharma

Eurofins Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Eurofins Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Eurofins Pink Sheet

Eurofins Scientific financial ratios help investors to determine whether Eurofins Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eurofins with respect to the benefits of owning Eurofins Scientific security.